Radient Technologies Inc.

(RTI:CA)

By |

Radient extracts natural compounds from a range of biological materials using microwave assisted processing ("MAP™"), a patented technology platform which provides superior customer outcomes in terms of ingredient purity, yield, and cost. From its 20,000 square foot manufacturing plant in Edmonton, Alberta, Radient serves market leaders in industries that include pharmaceutical, food, beverage, natural health, personal care and biofuel markets. Visit www.radientinc.com for more information.

Technology

Microwave Assisted Processing (MAP™)

Radient's patented, proprietary Microwave Assisted Processing or MAP™ technology is based on the selective and localized heating of the moisture present in all natural materials using microwaves as the energy source.

In general, microwaves interact with materials in three ways:

  1. Reflective materials such as metals do not heat (i.e. they do not absorb energy, but rather reflect the energy).
  2. Transparent materials such as most liquids other than water do not heat or reflect. Microwaves pass right through them and are only absorbed to a small extent.
  3. Absorptive materials such as water absorb microwaves and are heated.

Microwaves do not heat by conduction or convection but rather dielectrically, which in simple terms means microwaves create heat when a material stops or slows the radiation causing it to deposit some of its energy, which is subsequently dissipated as heat. Because microwaves interact directly with the object being heated and because this interaction is related to both the chemical and dielectric properties of the object, it is possible to apply heat (or more precisely, energy) in ways that are not achievable by any other means. Furthermore, every material will absorb microwave energy to a different extent, with individual parts of that material will absorbing the energy differently.

Radient's technological advantage and expertise in selectively depositing microwave energy into different parts of a biomass' complicated chemical system form the core of our extraction advantage.

MAP™ Demonstration Facility

Radient's 1,800 square meter MAP™ Demonstration Facility is located in Edmonton, Alberta, Canada, 30 minutes from Edmonton International Airport.

In addition to being a showcase of the equipment, processes, and technologies that make up the MAP™ solution, the facility is also

  • ISO/GMP-compliant
  • capable of processing up to five metric tons per day of biomass, across a range of biomasses
  • includes a pilot-scale plant capable of processing 500-800kg/day of biomass for very high-value extracts

Management

Denis Taschuk, CA
President & CEO, Director

Mr. Taschuk has over twenty five years business experience including corporate strategy development, manufacturing, market development and finance. Prior to Radient, Mr. Taschuk was a partner and CEO of JAG Flocomponents LP. JAG Flocomponents LP manufactured industrial valves with operations in six countries and customers in over twenty countries. During his time with JAG Flocomponents, he oversaw the expansion of the Company into international markets. Mr. Taschuk is also a Director of Tyhee Gold Corp. (TDC: TSX.V) and was previously a Director of the International Diabetes Federation and a Director and Chair of the Board of the Canadian Diabetes Association. Mr. Taschuk is a Chartered Accountant and holds a Bachelor of Commerce Degree from the University of Alberta.


Steven Splinter, PHD
Chief Technology Officer


Dr. Splinter was the founding President of Radient. He is experienced in strategic planning, technical assessment and development of process technologies, business leadership, and engineering project management. Prior to founding Radient, Dr. Splinter served as Director of Chemical & Environmental Processes at BC Research, where he built and managed a team of scientists, engineers and technologists providing contract R&D services to various clients in the area of chemical and biochemical process development. Dr. Splinter is an expert in interfacial phenomena, having earned a Ph.D. in Engineering Science in 1994. He has authored or co-authored numerous scientific publications and patents and has been invited as a speaker at international science conferences. In 2003, Dr. Splinter was awarded a prestigious 5NR Science Award for Leadership in Sustainable Development for his work in advancing MAP(TM).
Stéphane Gagné, MSC
Vice President, Sales and Marketing


Stéphane has over 15 years of experience in the fields of cosmetics, nutritional supplements, pharmaceutical products and active ingredients. He previously held the position of VP Sales and Marketing (Asia) and Director Sales and Marketing (Nutrition) for Atrium Biotechnologies and was the Director Sales and Marketing for Aeterna-Zentaris
Prakash Hariharan, MBA
Chief Financial Officer


Formerly one of Canada's leading portfolio managers when he was at Front Street Capital focusing on technology and growth related investments. Prakash also spent time at Dominion Bond Rating Services, analyzing and rating structured investment products. He holds a Financial Engineering degree from York University, an MBA from the Schulich School of Business, and an undergraduate degree in Chemical Engineering.

Milo Fisher, CET, MBA
Operations Manager


Milo Fisher has over 15 years of experience in the biotechnology industry including production of commercial active pharmaceutical ingredients, scale-up, technology transfer and contract manufacturing. He is well versed in scheduling and overseeing all manufacturing operations under full cGMP as well as ensuring that all manufacturing staff are fully trained to operate unit equipment under GMP guidelines. Additionally, he provides solid leadership to materials management and related manufacturing support operations. He held positions with Apotex Fermentation, SYNSORB Biotech Inc. KS Avicenna and QSV Biologics Ltd. Currently, Milo is overseeing the construction and fit-up of the new ingredient manufacturing facility capable of processing 5 tons of material under ISO and GMP.
Tomasz Popek, PHD
Product and Process Development Manager


Tomasz has over 15 years of experience from pharmaceutical and medical devices industry. His interdisciplinary experience spanning areas of drug design, formulation and analytical development, development and technology transfer of manufacturing processes, cross-functional project management and process risk analysis. He began his career at Viscoplast S.A. (currently 3M Viscoplast SA) as Specialist in Technology & Development Department, carried out a preclinical drug discovery and development in Canadian Government Laboratories and prior to his position at Radient he held senior scientific position in Supratek Pharma Inc. Tomasz graduated from University of Wroclaw, with PhD in Organic Chemistry.\


Mike Cabigon
Chief Operating Officer and Director

Mike has over ten years of senior management experience including P&L responsibility for businesses generating from $40 million to $300 million in annual revenue. Prior to Radient, Mike was Vice President and General Manager in a private equity-backed business which ultimately sold for over $750,000,000, generating a significant return for shareholders. Most recently, Mike was Managing Partner of Foundation Equity, an Edmonton-based venture capital firm. Mike holds a B.Comm from the University of Alberta.


Additional Information

Radient Technologies Inc.

Profile

Radient extracts natural compounds from a range of biological materials using microwave assisted processing ("MAP™"), a patented technology platform which provides superior customer outcomes in terms of ingredient purity, yield, and cost. From its 20,000 square foot manufacturing plant in Edmonton, Alberta, Radient serves market leaders in industries that include pharmaceutical, food, beverage, natural health, personal care and biofuel markets. Visit www.radientinc.com for more information.

Contact Information

Website: www.radientinc.com
Email: infor@radientinc.com
Main Phone: +1 780 465-1318
Address: 8223 Roper Road
State: AB
City / Town: Edmonton
Country: CAN
Postal Code: T6E 6S4

Issuer Information

Exchange: CDX
CEO: Denis Taschuk
Issuer Type: CS - Common Stock
Sector/Industry: Cyclical
NAICS: Hazardous Waste
$ 0.50 $ 0. (0.00%)
Last Price 0.50 Change $ 0. Change % 0.00 Tick N/A
Bid 0.50 Bid Size 19,500.00 Ask 0.51 Ask Size 139,500.00
Open 0.51 High 0.51 Low 0.49 Prev Close 0.50
Last Trade Volume 376,550 52 Wk Hi 0.92 52 Wk Low 0.11
Market Cap 82.6 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 165,132,193.00 EPS (TTM) -0.06 PE Ratio N/A Exchange TSXV